Today’s news / Jyllands-Posten

Jyllands-Posten

Novo Nordisk has consistently supplied insulin pens to the health care system in South Africa, but that has now ended. The pharmaceutical giant is accused of giving higher priority to American obesity patients than South African diabetics.